T 0209/25 (Injection devices comprising a composition of hyaluronic acid and mepivacaine hydrochloride / TEOXANE) of 05.12.2025
- European Case Law Identifier
- ECLI:EP:BA:2025:T020925.20251205
- Date of decision
- 5 December 2025
- Case number
- T 0209/25
- Online on
- 7 January 2026
- Petition for review of
- -
- Application number
- 19180298.2
- IPC class
- A61P 17/16A61P 19/00A61K 8/73A61K 31/728A61P 17/00A61Q 19/08A61K 31/445A61P 17/02A61K 8/49A61P 17/18A61P 23/00A61P 1/02
- Language of proceedings
- English
- Distribution
- No distribution (D)
- Download
- Decision in English
- OJ versions
- No OJ links found
- Other decisions for this case
- -
- Abstracts for this decision
- -
- Application title
- INJECTION DEVICES COMPRISING A COMPOSITION OF HYALURONIC ACID AND MEPIVACAINE HYDROCHLORIDE
- Applicant name
- Teoxane
- Opponent name
- Laboratoires Vivacy
- Board
- 3.3.07
- Headnote
- -
- Relevant legal provisions
- European Patent Convention Art 56Rules of procedure of the Boards of Appeal Art 12(6)Rules of procedure of the Boards of Appeal Art 12(4)
- Keywords
- Inventive step - (no)
Late-filed evidence - admitted (no) - Catchword
- -
- Cited cases
- T 2342/16
- Citing cases
- -
Order
For these reasons it is decided that:
The appeal is dismissed.